COM:BENITEC
Benitec Biopharma Inc.
- Stock
Last Close
10.20
22/11 21:00
Market Cap
89.46M
Beta: -
Volume Today
22.17K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -10.84M - | -8.83M 18.53% | -18.50M 109.62% | -4.37M 76.37% | -8.55M 95.56% | 2.61M 130.51% | -8.27M 417.13% | -13.88M 67.78% | -18.21M 31.16% | -19.56M 7.44% | -21.75M 11.19% | |
depreciation and amortization | 217K - | 158K - | 374K 136.71% | 424K 13.37% | 392K 7.55% | 381K 2.81% | 343K 9.97% | |||||
deferred income tax | -819.52K - | -957.20K - | -714K - | |||||||||
stock based compensation | 386K - | 957.20K - | 237K 75.24% | 634K 167.51% | 870K 37.22% | 452K 48.05% | 830K 83.63% | |||||
change in working capital | 760K - | 1.32M - | 126K 90.48% | 8K 93.65% | 1.04M 12,862.50% | 714K 31.15% | ||||||
accounts receivables | 607K - | 2.40M 294.73% | 28K 98.83% | 1.00K 96.43% | -50K 5,100.00% | |||||||
inventory | -700K - | -83K 88.14% | -1.09M 1,214.46% | -1.31M 19.80% | ||||||||
accounts payables | 740K - | -1.70M 329.19% | 55K 103.24% | 1.09M 1,881.82% | 1.36M 24.50% | |||||||
other working capital | 760K - | -24K - | 126K 625% | 8K 93.65% | 1.04M 12,862.50% | 714K 31.15% | ||||||
other non cash items | 1.14M - | -864.59K 175.60% | -1.70M 97.12% | -4.47M 162.58% | 700K - | 2K 99.71% | -16K 900% | 10K 162.50% | 717K 7,070% | |||
net cash provided by operating activities | -9.69M - | -9.69M 0% | -20.21M 108.50% | -8.30M 58.91% | -8.55M 2.97% | 4.79M 156.02% | -7.54M 257.31% | -12.83M 70.30% | -15.90M 23.90% | -18.01M 13.29% | -19.40M 7.72% | |
investments in property plant and equipment | -475.46K - | -387.34K 18.53% | -255.40K 34.06% | -131.41K 48.55% | -60.97K 53.60% | -403.40K 561.62% | -95K 76.45% | -221K 132.63% | -13K 94.12% | -1K 92.31% | -179K 17,800% | |
acquisitions net | 4.00K - | 1.00K 75.00% | ||||||||||
purchases of investments | -131K - | |||||||||||
sales maturities of investments | ||||||||||||
other investing activites | 30.33K - | -47.01K 254.99% | 202.03 100.43% | -0.00 100.00% | ||||||||
net cash used for investing activites | -475.46K - | -387.34K 18.53% | -255.40K 34.06% | -232.07K 9.13% | -107.99K 53.47% | -399.19K 269.67% | -94K 76.45% | -221K 135.11% | -13K 94.12% | -1K 92.31% | -179K 17,800% | |
debt repayment | ||||||||||||
common stock issued | 362.48K - | 295.30K 18.53% | 14.53M 4,821.81% | 6.20M 57.32% | 6.48M 4.45% | 2.25M - | 25.75M 1,044.44% | 17.88M - | ||||
common stock repurchased | ||||||||||||
dividends paid | -619K - | |||||||||||
other financing activites | -313.52K - | -255.41K 18.53% | -1.46M 470.73% | -102.20K 92.99% | -229.93K 124.97% | -480K - | -3.23M 572.50% | -1.87M - | 68.65M 3,772.98% | |||
net cash used provided by financing activities | 48.96K - | 39.88K 18.53% | 13.08M 32,685.41% | 6.10M 53.34% | 6.25M 2.43% | -688.11K 111.01% | 1.77M 357.22% | 22.52M 1,172.43% | 16.02M - | 68.03M 324.78% | ||
effect of forex changes on cash | 539.48K - | 439.49K 18.53% | -386.09K 187.85% | -144.47K 62.58% | 105.78K 173.22% | 727.65K 587.89% | -58K 107.97% | 499K 960.34% | 204K 59.12% | 412K 101.96% | -8K 101.94% | |
net change in cash | -9.01M - | -7.34M 18.53% | -2.66M 63.82% | -657.03K 75.27% | -947.62K 44.23% | 4.43M 567.52% | -5.92M 233.56% | 9.97M 268.46% | -15.71M 257.58% | -1.59M 89.90% | 48.44M 3,154.16% | |
cash at beginning of period | 29.52M - | 24.05M 18.53% | 16.27M 32.36% | 14.01M 13.90% | 12.76M 8.89% | 11.26M 11.74% | 15.72M 39.53% | 9.80M 37.64% | 19.78M 101.86% | 4.08M 79.40% | 2.49M 38.91% | |
cash at end of period | 20.51M - | 16.71M 18.53% | 13.61M 18.53% | 13.35M 1.92% | 11.82M 11.50% | 15.70M 32.83% | 9.80M 37.55% | 19.77M 101.70% | 4.08M 79.38% | 2.49M 38.91% | 50.93M 1,945.34% | |
operating cash flow | -9.69M - | -9.69M 0% | -20.21M 108.50% | -8.30M 58.91% | -8.55M 2.97% | 4.79M 156.02% | -7.54M 257.31% | -12.83M 70.30% | -15.90M 23.90% | -18.01M 13.29% | -19.40M 7.72% | |
capital expenditure | -475.46K - | -387.34K 18.53% | -255.40K 34.06% | -131.41K 48.55% | -60.97K 53.60% | -403.40K 561.62% | -95K 76.45% | -221K 132.63% | -13K 94.12% | -1K 92.31% | -179K 17,800% | |
free cash flow | -10.17M - | -10.08M 0.87% | -20.46M 103.02% | -8.44M 58.78% | -8.61M 2.09% | 4.39M 150.94% | -7.63M 273.94% | -13.05M 71.07% | -15.91M 21.90% | -18.01M 13.20% | -19.58M 8.71% |
All numbers in USD (except ratios and percentages)